Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: A mathematical modelling analysis

AIDS

Volumn 26, Issue 11, 2012, Pages 1403-1413

  Estill, Janne ^a   Aubrière, Cindy ^a   Egger, Matthias ^a   Johnson, Leigh ^b   Wood, Robin ^b   Garone, Daniela ^c   Gsponer, Thomas ^a   Wandeler, Gilles ^a,e   Boulle, Andrew ^b   Davies, Mary Ann ^b   Hallett, Timothy B ^d   Keiser, Olivia ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c MÉDECINS SANS FRONTIÈRES   (Switzerland)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

HIV transmission; mathematical model; second line therapy; Southern Africa; test and treat; therapy failure; viral load monitoring

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AFRICA; ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MORTALITY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TREATMENT FAILURE; TREATMENT RESPONSE; VIRUS LOAD; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA, SOUTHERN; ALGORITHMS; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MODELS, THEORETICAL; PREDICTIVE VALUE OF TESTS; VIRAL LOAD;

EID: 84863715593     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283536988     Document Type: Article

References (41)

1. World Heath Organization/UNAIDS/UNICEF. Global HIV/AIDS Response: Epidemic update and health sector progress towards Universal Access, (2011). http://www.who.int/hiv/pub/progress-report2011/hiv-full-report-2011.pdf. [Accessed 17 February 2011].
2. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000; 342:921-929. (Pubitemid 30177052)
3. Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009; 23:1397-1404.
4. Anglemyer A, Rutherford GW, Egger M, Siegfried N. Antiretroviral therapy for prevention of HIV transmission in HIVdiscordant couples (Review). Cochrane Database Syst Rev. 2011:CD009153.
5. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
6. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009; 373:48-57.
7. Mastro TD, Cohen MS. Honing the test-and-treat HIV strategy. Science 2010; 328:976.
8. Charlebois ED, Havlir DV. "A Bird in the hand.": a commentary on the test and treat approach for HIV. Arch Intern Med 2010; 170:1354-1356.
9. Bacaer N, Pretorius C, Auvert B. An age-structured model for the potential impact of generalized access to antiretrovirals on the South African HIV epidemic. Bull Math Biol 2010; 72:2180-2198.
10. Dodd PJ, Garnett GP, Hallett TB. Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings. AIDS 2010; 24:729-735.
11. Keiser O, Orrell C, Egger M, Wood R, Brinkhof MW, Furrer H, et al. Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared. PLoS Med 2008; 5:e148.
12. Keiser O, Macphail P, Boulle A, Wood R, Schechter M, Dabis F, et al. Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy. Trop Med Int Health 2009; 14:1220-1225.
13. Mee P, Fielding K, Charalambous S, Churchyard GJ, Grant AD. Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa. AIDS 2008; 22:1971-1977.
14. Keiser O, Chi BH, Gsponer T, Boulle A, Orrell C, Phiri S, et al. Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa. AIDS 2011; 25:1761-1769.
15. Egger M, Ekouevi DK, Williams C, Lyamuya RE, Mukumbi H, Braitstein P, et al. Cohort profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa. Int J Epidemiol 2011 [Epub ahead of print].
16. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2010 revision. 2010. http://whqlibdoc. who.int/publications/2010/9789241599764-eng. pdf. [Accessed 17 February 2012].
17. Actuarial society of South Africa, (2011). http://www.actuarial society.org.za/. [Accessed 24 September 2011].
18. Hallett TB, Gregson S, Dube S, Garnett GP. The impact of monitoring HIV patients prior to treatment in resource-poor settings: insights from mathematical modelling. PLoS Med 2008; 5:e53.
19. Petersen ML, van der Laan MJ, Napravnik S, Eron JJ, Moore RD, Deeks SG. Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification. AIDS 2008; 22:2097-2106.
20. Das M, Chu PL, Santos G-M, Scheer S, Vittinghoff E, McFarland W, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One 2010; 5:e11068.
21. Wilson DP, Law MG, Grulich AE, Cooper DA, Kaldor JM. Relation between HIV viral load and infectiousness: a modelbased analysis. Lancet 2008; 372:314-320. (Pubitemid 352020440)
22. Fox MP, Sanne IM, Conradie F, Zeinecker J, Orrell C, Ive P, et al. Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/ml is associated with improved treatment outcomes in South Africa. AIDS 2010; 24:2041-2050.
23. Egger M, Spycher BD, Sidle J, Weigel R, Geng E, Fox MP, et al. Correcting mortality for loss to follow up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa. PLoS Med 2011; 8:e1000390.
24. National Antiretroviral Treatment Guidelines for Adults, Adolescents, and Children. 3rd ed. Ministry of Health of Uganda, (2009). http://www.idi.ac.ug/ docs/guidelines%202009.pdf. [Accessed 17 February 2012].
25. Johns Hopkins Point-of-Care Information Technology (POC-IT) Center. HIV Guide-Zambia. Zambia National HIV Guidelines. Baseline evaluation and monitoring, (2008). http://www. zambiahivguide.org/guidelines/index.html? categoryId=429187 &siteId=429188. [Accessed 20 March 2012].
26. World Health Organization. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: Progress Report, (2010). http://www.who.int/hiv/pub/2010progressre port/full-report-en.pdf. [Accessed 17 February 2012].
27. Wandel S, Egger M, Rangsin R, Nelson KE, Costello C, Lewden C, et al. Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies. Sex Transm Infect 2008; 84 (Suppl 1):i31-i36.
28. Bunnell R, Opio A, Musinguzi J, Kirungi W, Ekwaru P, Mishra V, et al. HIV transmission risk behavior among HIV-infected adults in Uganda: results of a nationally representative survey. AIDS 2008; 22:617-624. (Pubitemid 351640594)
29. Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009; 360:1815-1826.
30. The HIV-CAUSAL Collaboration. When to Initiate Combined Antiretroviral Therapy to Reduce Mortality and AIDS-Defining Illness in HIV-Infected Persons in Developed Countries: an observational study. Ann Intern Med 2011; 154:509-515.
31. Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, et al. Timing of initiation of antiretroviral therapy in AIDSfree HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009; 373:1352-1363.
32. Wright ST, Carr A, Woolley I, Giles M, Hoy J, Cooper DA, et al. CD4 cell responses to combination antiretroviral therapy in patients starting therapy at high CD4 cell counts. J Acquir Immune Defic Syndr 2011; 58:72-79.
33. Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med 1999; 131: 81-87. (Pubitemid 29340558)
34. Phillips AN, Staszewski S, Weber R, Kirk O, Francioli P, Miller V, et al. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA 2001; 286:2560-2567. (Pubitemid 33096807)
35. Powers KA, Ghani AC, Miller WC, Hoffman IF, Pettifor AE, Kamanga G, et al. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. The Lancet 2011; 378:256-268.
36. Cohen MS, Shaw GM, McMichael AJ, Haynes BF. Medical progress: acuteHIV-1infection.NEngl JMed2011;364:1943-1954.
37. Bunnell R, Ekwaru JP, Solberg P, Wamai N, Bikaako-Kajura W, Were W, et al. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 2005; 20:85-92.
38. Pingen M, Nijhuis M, de Bruijn JA, Boucher CAB, Wensing AMJ. Evolutionary pathways of transmitted drug-resistant HIV-1. J Antimicrob Chemother 2011; 66:1467-1480.
39. Barth RE, van der Loeff MFS, Schuurman R, Hoepelman AIM, Wensing AMJ. Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review. Lancet Infect Dis 2010; 10:155-166.
40. Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, et al. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care 2006; 44:990-997. (Pubitemid 44674030)
41. Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, Cooper CL, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med 2011; 155:209-216.